(See the major article by Von Dach et al on pages 1370-9.)
The epidemiology of Staphylococcus aureus is rapidly changing. Methicillinresistant S. aureus (MRSA) infections have long been associated with healthcare institutions. However, since the beginning of the 1990s, MRSA infections have also been identified in community settings and associated with outbreaks in remote populations, children, prisoners, and sports teams. The clinical manifestations of these infections are similar worldwide: moderate-to-severe skin and soft tissue infections (SSTIs), including furunculosis, often in children and young adults. Invasive infections, such as necrotizing pneumonia, bacteremia, and infectious endocarditis, have also been reported, but less frequently [1] . Several major MRSA clones (generally referred to as community-acquired MRSA [CA-MRSA]) with worldwide distribution have been implicated in these infections. The core genomes of these clones are genetically diverse, but they share a conserved repertoire of key accessory elements, including a Panton-Valentine leukocidin (PVL)-encoding phage and a short staphylococcal cassette chromosome mec (SCCmec) element. In Europe, where the prevalence of these infections remains low, most reported cases involve the ST80 clone [2] .
By contrast, the Americas have faced a major epidemic caused by a particular clone, USA300, in both community and healthcare settings. Over the past 2 decades, USA300 MRSA, which was initially associated with infections in the United States, has been reported in an increasing number of countries, and this clone is now established on 5 continents [3] . Recent studies in various countries have suggested that the USA300 clone is replacing the locally established CA-MRSA clones. Given its virulence and potential to cause epidemics, the USA300 clone has become an international cause of concern.
The factors contributing to the successful epidemiological evolution of the USA300 clone remain obscure. It has been suggested that the arginine catabolism mobile element (ACME), which carries deaminase genes and is harbored by the subpopulation of USA300 strains that has spread in the United States and Canada (named USA300 ST8-SCCmec IVa), promotes the survival of the bacterium in the acidic skin environment, thereby contributing to its dissemination [4] . However, strains from the subpopulation of USA300 strains not carrying ACME in their genomes (USA300 ST8-SCCmec IVc, Latin American variant) have nevertheless also been reported and have successfully spread in South American countries and, more recently, in Europe [5] . Furthermore, a recent study of the porcine carriage of MRSA raised the possibility of the existence of an animal reservoir [6] . Finally, the epidemiology of this clone is probably very complex.
Epidemiological studies at the international, national, regional, and local levels are required, to monitor the spread of the USA300 clone and to identify the factors contributing to its success. Such knowledge will be essential for the development of effective measures to prevent the further uncontrolled spread of this clone, particularly in healthcare institutions.
Over the past 2 decades, sequencing technology has opened up new possibilities for the analysis of genomes of pathogenic bacteria. The expanding field of genomics has provided powerful tools and insight for studies of pathogen epidemiology. Whole-genome sequencing (WGS) provides the means to detect minor variation, down to the level of single-nucleotide variants. These techniques are, therefore, likely to prove more discriminatory than conventional epidemiological typing. The article by Von Dach et al in this issue of The Journal of Infectious Diseases reports the application of such genomic typing tools to the study of S. aureus USA300 and USA300-like strains. With the aim of investigating the reasons for the observed increase in the prevalence of CA-MRSA USA300 in the Geneva region, Switzerland, the authors used WGS techniques on all their MRSA isolates. They demonstrated an absence of local spread of the USA300 clone and of healthcareassociated transmission for this clone, identified several intrafamilial transmission events, and showed that the strains responsible for colonization and infections in the region concerned were evenly distributed between 2 very different subpopulations of USA300 strains that may have evolved independently: first, a genetically homogeneous ACME-positive subpopulation, containing strains highly similar to those observed in the United States, and, second, a more heterogeneous subpopulation of ACME-negative strains similar to those reported in South America. By contrast, conventional typing tools (ie, antibiotic susceptibility, pulsed-field gel electrophoresis, and spaand SCCmec-typing) provided evidence for ongoing CA-MRSA USA300 spread in the region. These results confirm the particular complexity encountered in the epidemiological evolution of the USA300 clone and demonstrate the limitations of conventional typing tools and their inadequacy for microepidemiological studies of CA-MRSA USA300. Further investigations of this clone will clearly require the use of genomic tools.
Another important goal of research on the troublesome USA300 clone is to increase substantially our understanding of its pathogenicity and its evolutionary adaptation during the transition from colonizer to invasive pathogen. The genetic features associated with the occurrence of infections caused by this clone, benign SSTIs and life-threatening diseases, have yet to be determined. Outside of outbreak settings, little is known about the prevalence of carriage of S. aureus USA300 in the general population in many countries and the specific characteristics of the colonizing strains. The article by Von Dach et al suggests a greater capacity of strains from the USA300 Latin variant subpopulation to cause infections. However, the strains of this subpopulation could not be distinguished from the USA300 ACME-positive strains on the basis of the presence of virulence-associated genes and mobile genetic elements in the genome. Further studies, expanding on this WGS analysis, with strains recovered from diverse geographic areas and epidemiological settings (colonization, SSTIs, and invasive infections) should rapidly extend our knowledge of the pathogenicity of the different subpopulations of strains within the USA300 clone. Fascinating times lie ahead! Note Potential conflict of interest. Author certifies no potential conflicts of interest. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
